ZECCA, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 560
AS - Asia 334
EU - Europa 67
SA - Sud America 4
AF - Africa 3
OC - Oceania 1
Totale 969
Nazione #
US - Stati Uniti d'America 557
SG - Singapore 266
CN - Cina 28
FI - Finlandia 19
KR - Corea 18
IT - Italia 16
HK - Hong Kong 9
AZ - Azerbaigian 4
DE - Germania 4
FR - Francia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
IE - Irlanda 3
DK - Danimarca 2
GR - Grecia 2
IN - India 2
MA - Marocco 2
PA - Panama 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
BY - Bielorussia 1
CA - Canada 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GB - Regno Unito 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
NL - Olanda 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 969
Città #
Santa Clara 460
Singapore 136
Helsinki 19
Seoul 18
Guangzhou 17
Hong Kong 9
Los Angeles 7
Milan 5
Baku 4
Brescia 3
Dublin 3
Falkenstein 3
St Louis 3
Chennevières-sur-Marne 2
Lisbon 2
Ahmedabad 1
Amman 1
Ashburn 1
Athens 1
Auckland 1
Aulnay-sous-Bois 1
Biassono 1
Bishkek 1
Bogotá 1
Bratislava 1
Buenos Aires 1
Cairo 1
Chisinau 1
Colombo 1
Copenhagen 1
Delhi 1
Dubai 1
Forest City 1
La Paz 1
Lima 1
London 1
Minsk 1
Novara 1
Phoenix 1
Prague 1
Rabat 1
Riga 1
San Francisco 1
Tallinn 1
Tirana 1
Vienna 1
Totale 722
Nome #
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 23
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 22
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 19
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 19
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals 18
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 18
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 17
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 15
The role of neuromelanins in the oxidative stress of Parkinson's disease. 14
Neuromelanin organelles pathways in brain aging and Parkinson's disease 14
Neuromelanin organelle pathways in aging and neurodegeneration of Parkinson's Disease 14
Melanic Pigments in the Human brain 13
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 13
Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure 13
Neuromelanin of the Human Substantia Nigra: An Update 13
Protective and toxic roles of dopamine in Parkinson's disease 13
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. 12
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 12
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 12
Synthetic models of neuromelanin with fibrillated protein in the core 12
The role of neuromelanin organelle pathways in parkinson's disease 12
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 12
Neuromelanin-sensitive MRI as a proxy-measure of dopamine function in neuropsychiatric illness. 12
Contrast mechanisms associated with neuromelanin-MRI 12
Melanin-protein fibrils conjugates as models to study neuromelanin structure and reactivity. 12
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 11
Neuromelanins Isolated from Different Regions of the Human Brain Exhibit a Common Surface Photoionization Threshold 11
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 11
NEUROMELANINS ACCUMULATE IN NEURONS DURING HUMAN BRAIN AGING AND BIND METALS 11
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin. 11
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 11
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease 11
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. 11
NEUROMELANIN ORGANELLES AND AUTOPHAGY IN BRAIN AGING 11
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside 10
NEUROMELANIN ORGANELLES PATHWAYS AND NEURODEGENERATION IN PARKINSON'S DISEASE 10
The Role of Iron in Neurodegeneration 10
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids. 10
Proteomic profile of neuromelanin and neuromelanin-containing organelles 10
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis. 10
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease 10
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease 9
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease. 9
Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis 9
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI 9
Engineered nanoparticles. How brain friendly is this new guest? 9
Protective and neurotoxic role of neuromelanin in human brain 9
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 9
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 9
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 9
The protective and toxic role of neuromelanins in brain aging and Parkinson's disease 8
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism 8
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 8
Neuromelanins in brain aging and Parkinson's disease. 8
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease 7
Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra 7
Iron and copper molecules in aging of human substantia nigra. Consequences for neurodegenerative processes. 7
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes. 7
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. 7
Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. 7
Molecular understanding of aluminum bioinorganic chemistry in relevance to the pathology of Alzheimer's disease 7
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. 7
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry 7
Neuromelanin activates microglia and induces substantia nigra neuron death. 7
Neuromelanin activates microglia and induces substantia nigra neuron death. A key mechanism of Parkinson's disease. 7
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference. 7
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 7
Effect of prolonged exposure to 50 Hz electric and magnetic fields on neurotransmitters in rat brain 6
The neuromelanin of human substantia nigra and its interaction with metals 6
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage 6
Elaboration of chemical degradative approach to characterizing neuromelanins form various brain regions 6
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes 6
Activation of microglia by neuromelanin: correlation of neuromelanin phagocytosis and degradation, reactive oxygen species production, and ventral midbrain neuron death. 6
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 6
The in vivo detection of iron and neuromelanin by Transcranial Sonography: a potential approach for early diagnosis of Parkinson's Disease 6
The structure, synthesis and role of neuromelanins in brain aging and neurodegeneration 6
Iron, copper and their proteins in substantia nigra of human brain during aging. 6
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells 5
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin. 5
Iron, brain ageing and neurodegenerative disorders. 5
A modern imaging investigation of neuromelanin extracted from the substantia nigra region of the human brain. 5
The role of iron in brain ageing and neurodegenerative disorders 5
Iron-binding characteristics of neuromelanin of the human substantia nigra. 5
Chemistry and biophysics of melanins 5
Neuromelanins, oxidative stress and Parkinson's disease 5
The in vivo detection of iron and ferritins by transcranial sonography: A new approach for early diagnosis of Parkinson's disease 5
The application of the Neutron Activation Analysis for trace metals determination in human brain tissues and substantia nigra neuromelanin. 5
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus 5
The role of neuromelanin in brain aging and Parkinson's disease. 5
The role of neuromelanin in brain aging and Parkinson's disease. 5
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration 5
Iron, copper and zinc concentration in substantia nigra of human brain during aging. 5
NEURONAL MHC-I DISPLAY IN T-CELL MEDIATED NEURODEGENERATION 5
Effetti dell'esposizione cronica a CEM di 50 Hz su neurotrasmettitori e recettori nel cervello di ratto 5
Neuromelanin in the human brain: protective and toxic role. 5
Neuromelanin and metals in brain aging and neurodegeneration. 5
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics 5
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 5
Neuromelanin a chelator of iron and other metals in catecholaminergic neurons of substantia nigra and locus coeruleus. 4
Protective and toxic role of neuromelanin in brain aging and Parkinson's disease 4
Totale 912
Categoria #
all - tutte 4.880
article - articoli 2.780
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 76
Totale 7.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202449 0 0 0 0 0 0 0 0 2 0 45 2
2024/2025979 3 9 171 73 444 48 24 144 55 8 0 0
Totale 1.028